Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

PETRI DISH PERSPECTIVES

PETRI DISH PERSPECTIVES artwork

Episode 80: Dr. Meesha Dogan on Using AI and Epigenetics to Detect Heart Disease Early

Nov 5, 202647 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Send us Fan Mail After a two-generation family history of heart disease, Dr. Meesha Dogan set out to change how the disease is detected. As founder and CEO of Cardio Diagnostics, she built and commercialized what the company describes as the first epigenetics-based clinical test for heart disease driven by AI, then took the company public on Nasdaq in 2022. Since then, it has earned a dedicated AMA CPT code for its PrecisionCHD test, won a Vizient innovative technology contract, and launched its first international partnership in India. In this episode, Dr. Dogan unpacks why roughly 80% of cardiovascular events are preventable yet still so often missed, how combining genetics and epigenetics gives a fuller picture of heart disease risk, and what it takes to move a diagnostic from the lab to reimbursement, health systems, and employers. Check out Cardio Diagnostics: https://www.cdio.ai/ 🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday! https://linktr.ee/maneadkhin #PetriDishPerspectives #Cardiology #HeartHealth #Epigenetics #AIinHealthcare #PrecisionMedicine #Diagnostics #Biotech #HealthTech #PreventiveMedicine #WomenInSTEM #CardioDiagnostics Support the show © 2026 The Perspective Bureau LLC. All rights reserved.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Episode 82: Dr. Natalie Ma on Building Virtual Humans to Predict Drug Safety

    Nov 19, 202655 minAudio

    Send us Fan Mail After earning a PhD in molecular biology at Yale, Dr. Natalie Ma moved from the bench to the business side of science to tackle drug development’s biggest problem: roughly 90% of programs fail, often...

    Credit the people on this episode

  2. Episode 81: Mithril Medicine (Now Anthropic)

    Nov 12, 202626 minAudio

    Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Mithril Medicine, the one-person biotech that Anthropic just acquired and the story behind the man who built it. Cody Tranbarger spent six years...

    Credit the people on this episode

  3. October 2026: Biotech & Pharma NEWS Roundup

    Nov 1, 20269 minAudio

    Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for October 2026! This month was defined by a wave of oncology approvals, a head-to-head data drop that reshuffled...

    Credit the people on this episode

  4. Episode 79: Endeavor Health

    Oct 29, 202617 minAudio

    Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Endeavor Health, the Chicago-area hospital system most Illinoisans have driven past but couldn’t name. Born from Evanston Hospital in 1891, grown...

    Credit the people on this episode

  5. Episode 78: Dr. Kristin Gleitsman on Using AI to Make Better Drug Development Decisions

    Oct 22, 202643 minAudio

    Send us Fan Mail After years of building discovery engines inside diagnostics, Kristin Gleitsman has become one of the more skeptical voices in AI and biology. A Caltech chemistry PhD, Kristin built Veracyte’s Discovery...

    Credit the people on this episode